CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
EnglishRON is a tyrosine kinase receptor activated by the macrophage-stimulating protein (MSP) ligand that is overexpressed in human breast cancer. In humans, RON protein can be present in different isoforms, and the most studied isoform is represented by the short form of RON (sf-RON), which is generated by an alternative promoter located in intron 10 of the RON complementary DNA (cDNA). It plays an important role in breast cancer progression. Considering the many similarities between feline mammary carcinoma (FMC) and human breast cancer, the aim of this study was to investigate the expression of both RON and MSP in FMCs and to identify the presence of the sf-RON transcript. Tissue samples of spontaneous mammary tumors were collected from 60 queens (10 benign lesions, 50 carcinomas). All of the samples were tested for RON and MSP expression by immunohistochemistry; moreover, RNA was extracted from paraffin-embedded tissue samples, and the cDNA was tested by reverse transcription–polymerase chain reaction (RT-PCR) to identify the presence of sf-RON. Immunohistochemistry detected the expression of RON and MSP in 34 of 50 (68%) and 29 of 50 (58%) FMCs, respectively. RT-PCR revealed the presence of the shortform in 18 of 47 (38%) FMCs. This form originates, as in humans, from an alternative promoter (P2), and it codes for the proper feline short form (sf-RON). sf-RON expression was associated with poorly differentiated tumors and with a shorter disease-free (P < .05; hazard ratio [HR], 2.2) period and a shorter survival (P < .05; HR, 2.2). These results support FMC as a suitable model in comparative oncology and identify sf-RON expression as potential predictor of outcomes for this disease.
| Titolo: | Expression of the Short Form of RON/STK in Feline Mammary Carcinoma |
| Autori Riconosciuti: | |
| Autori: | Lorella Maniscalco, Silvia Guil-Luna, Selina Iussich, Francesca Gattino, Calogero Trupia, Yolanda Millan,Juana Martı´n de Las Mulas, Raquel Sanchez Cespedez, K. Saeki, Paolo Accornero, Raffaella De Maria |
| Data di pubblicazione: | 2019 |
| Abstract: | RON is a tyrosine kinase receptor activated by the macrophage-stimulating protein (MSP) ligand that is overexpressed in human breast cancer. In humans, RON protein can be present in different isoforms, and the most studied isoform is represented by the short form of RON (sf-RON), which is generated by an alternative promoter located in intron 10 of the RON complementary DNA (cDNA). It plays an important role in breast cancer progression. Considering the many similarities between feline mammary carcinoma (FMC) and human breast cancer, the aim of this study was to investigate the expression of both RON and MSP in FMCs and to identify the presence of the sf-RON transcript. Tissue samples of spontaneous mammary tumors were collected from 60 queens (10 benign lesions, 50 carcinomas). All of the samples were tested for RON and MSP expression by immunohistochemistry; moreover, RNA was extracted from paraffin-embedded tissue samples, and the cDNA was tested by reverse transcription–polymerase chain reaction (RT-PCR) to identify the presence of sf-RON. Immunohistochemistry detected the expression of RON and MSP in 34 of 50 (68%) and 29 of 50 (58%) FMCs, respectively. RT-PCR revealed the presence of the shortform in 18 of 47 (38%) FMCs. This form originates, as in humans, from an alternative promoter (P2), and it codes for the proper feline short form (sf-RON). sf-RON expression was associated with poorly differentiated tumors and with a shorter disease-free (P < .05; hazard ratio [HR], 2.2) period and a shorter survival (P < .05; HR, 2.2). These results support FMC as a suitable model in comparative oncology and identify sf-RON expression as potential predictor of outcomes for this disease. |
| Volume: | 56 |
| Fascicolo: | 2 |
| Pagina iniziale: | 220 |
| Pagina finale: | 229 |
| Digital Object Identifier (DOI): | 10.1177/0300985818806967 |
| URL: | https://journals.sagepub.com/doi/full/10.1177/0300985818806967?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed |
| Parole Chiave: | cats, feline mammary tumors, short form of RON, comparative oncology, prognosis |
| Rivista: | VETERINARY PATHOLOGY |
| Appare nelle tipologie: | 03A-Articolo su Rivista |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| RON_IRIS_VETH PATH.pdf | PREPRINT (PRIMA BOZZA) | Open Access Visualizza/Apri |
Copyright © 2021